Aclarion (ACON) Capital Expenditures (2024 - 2025)
Aclarion's (ACON) quarterly Capital Expenditures came in at $13726.0 in Q4 2025, up 168.35% YoY from $5115.0 in Q4 2024, and up 87.49% on a QoQ basis from $7321.0 in Q3 2025.
Aclarion (ACON) Capital Expenditures (2024 - 2025) Analysis & Trends
Aclarion (ACON) has 2 years of Capital Expenditures data on file, last reported at $13726.0 in Q4 2025.
- Quarterly Capital Expenditures rose 168.35% year-over-year to $13726.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26162.0 (changed N/A YoY) and the FY2025 annual result came in at $21528.0, up 320.88% from the prior year.
- Capital Expenditures climbed to $13726.0 in Q4 2025, from $7321.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $13726.0 in Q4 2025 to a low of $5115.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 1.75 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 29.03 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 15.93 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 1.59 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 1.73 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 56.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 16.11 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 2.32 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Aclarion | 6.06 Mn | 6.06 Mn | 8,297.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,726.00 |
| Dec 31, 2025 | 13,726.00 |
| Sep 30, 2025 | 7,321.00 |
| Sep 30, 2025 | 7,321.00 |
| Dec 31, 2024 | 5,115.00 |
| Dec 31, 2024 | 5,115.00 |